Healthtech Startups

Cogent Biosciences is a biotechnology company developing small molecule precision therapies for genetically driven diseases where the cause is linked to a specific genetic mutation. It runs a discovery organization in Boulder, Colorado, aiming to create treatments for patients with unmet medical needs.

3 investors

UpDoc builds agentic clinical AI that connects with patients between appointments to gather structured health data, coordinate with care teams, and deliver physician-prescribed interventions for chronic disease management. It is designed for enterprise health systems, providers, and payers, with integration into EHR environments and clinical workflows.

3 investors

Updox provides digital charge capture and revenue cycle management solutions for medical practices, enabling automated billing and payment processing.

3 investors

Uplift Labs builds AI-powered motion-capture and biomechanics technology that turns iPhones into movement-analysis tools, providing performance analytics and injury prevention for athletes in sports and fitness. Its offerings serve areas such as golf, baseball, and general training and coaching.

3 investors

Upside provides end-to-end housing stabilization services for individuals experiencing housing instability within healthcare settings, serving health plans, employers, and their members across Medicaid, Medicare, and employer coverage. The company coordinates case management, local navigation, and community partnerships to resolve complex housing situations and improve health outcomes.

3 investors

Upstream Rehabilitation operates a network of over 1,200 outpatient physical therapy clinics across 28 U.S. states, providing patient rehabilitation care. It also acquires and partners with physical therapy practices, offering full sales or equity-retaining partnerships.

3 investors

UroDev Medical manufactures connected medical devices for people with spinal cord injury and disease, starting with a catheter designed to address neurogenic bladder and urinary incontinence.

3 investors

UroGen is a biotech company developing treatments for urothelial and specialty cancers using a proprietary sustained-release hydrogel platform technology. The company commercializes approved therapies for bladder and upper tract cancers, with additional candidates in development.

3 investors

USHP develops technology and care solutions for cardiovascular health, serving physicians and medical practices. The company focuses on integrating innovative tools to improve heart care delivery and patient outcomes.

3 investors

Us2.ai provides FDA-cleared AI software that automatically analyzes echocardiograms and generates structured clinical reports in real time. The platform detects cardiac diseases including amyloidosis, aortic stenosis, heart failure, and valvular disease, integrating seamlessly with existing ultrasound devices and hospital infrastructure.

3 investors

Terrestrial develops the Tacterra microarray patch platform, a dissolvable skin-patch technology for delivering therapies including GLP-1 without injection. The platform targets patients seeking more convenient, pain-free administration of next-generation therapeutics.

3 investors

Valant provides software solutions for behavioral healthcare organizations to improve clinical outcomes and operational efficiency. The platform serves behavioral health practices and treatment centers seeking to streamline care delivery and practice management.

3 investors

VALD provides measurement and monitoring systems for assessing musculoskeletal performance across strength, movement, speed, and balance in athletic and rehabilitation settings. The company offers integrated hardware sensors and a centralized platform called VALD Hub for data management and athlete performance tracking.

3 investors

Valley Steer uses machine learning and large language models to process and organize healthcare data for healthcare organizations. The platform transforms unstructured healthcare records into validated, structured data and reports.

3 investors

Valpas provides bed bug detection and prevention solutions for hotels, focusing on safety and sustainability in guest accommodations. The company addresses health and environmental concerns related to traditional pest control methods in the hospitality industry.

3 investors

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics. The company's management team specializes in mitochondrial function and neurological disease treatment.

3 investors

Vantis develops AI-based assistance systems and technology for primary care, aimed at supporting physicians in everyday clinical work by simplifying processes and making medical information more usable. The company builds its solutions around the practical requirements of primary care practices.

3 investors

Vapotherm manufactures high-velocity therapy devices for respiratory distress treatment across patient populations. The company serves healthcare providers and has treated over 4.1 million patients globally.

3 investors

Vastian provides a platform that helps hospital and laboratory professionals manage quality standards, competency assessments, and equipment sanitation policies. The company serves independent lab organizations and large health systems across the United States and globally.

3 investors

VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers. It also develops immuno-oncology products for companion animals, including treatments for mammary tumors and lymphoma.

3 investors

Vector Health helps rural hospitals identify uninsured and underinsured patients who qualify for financial assistance programs, using AI to unlock new revenue streams. The platform is built specifically for resource-constrained rural health systems with limited IT infrastructure.

3 investors

Velsera provides integrated software and expert services that turn complex biomedical and genomic data into usable insights for precision medicine, drug discovery, diagnostics development, and genetic testing. It serves organizations in the life sciences and healthcare sectors working on discovery, diagnostics, and regulatory navigation.

3 investors

3 investors

Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies. It serves medical spas, dermatologists, plastic surgeons, and hair transplant physicians across more than 60 countries.

3 investors